CSF2 and neoplasm: Through genetic modification, the deletion of the infected cell protein (ICP) 34.5 gene and the ICP47 gene, as well as the addition of granulocyte macrophage colony stimulating factor (GM-CSF), enhances the anti-tumor effect (49).